Skip to content

Clascoterone

Androgen Receptor Inhibitor — DERMATOLOGICALS

Also known as: breezula, CB-03-01, cortexolone 17alpha-propionate , winlevi

OfpFDA approvedATC D10AX06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Clascoterone is an ofp drug in the Androgen Receptor Inhibitor class catalogued in DrugCentral. It was first approved by the FDA in 2020. Its mechanism of action is classified as Androgen Receptor Antagonists. DrugCentral lists 1 molecular target, including AR. Recorded indications include Acne vulgaris.

  • Approval status: ofp (first approved 2020 by the FDA).
  • Drug class: Androgen Receptor Inhibitor.
  • Mechanism of action: Androgen Receptor Antagonists.
  • Molecular targets: AR (1 listed in DrugCentral).
  • Indications: Acne vulgaris.
  • ATC code: D10AX06 (Other anti-acne preparations for topical use).
  • Molecular formula: C24H34O5; molecular weight 402.53 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Acne vulgaris

Mechanism & targets

Mechanism of action (MoA)Androgen Receptor Antagonists
Established pharmacologic classAndrogen Receptor Inhibitor

Molecular targets (1)

TargetGeneActionActivity
Androgen receptorARantagonistIC50 7.30

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2020-08-26FDA—CASSIOPEA SPA

ATC classification

ATC codeTherapeutic hierarchy
D10AX06DERMATOLOGICALS › ANTI-ACNE PREPARATIONS › ANTI-ACNE PREPARATIONS FOR TOPICAL USE › Other anti-acne preparations for topical use

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Product storage error1493.4
Product physical consistency issue292.1
Product use complaint206.1

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Clascoterone is on its molecule page.

Molecular formulaC24H34O5
Molecular weight402.53 g/mol
CAS number19608-29-8
InChIKeyGPNHMOZDMYNCPO-PDUMRIMRSA-N
PubChem CID11750009
CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Clascoterone used for?

DrugCentral lists the following indications for Clascoterone: Acne vulgaris.

How does Clascoterone work?

Clascoterone is classified as Androgen Receptor Antagonists; its molecular targets in DrugCentral include AR (antagonist).

When was Clascoterone first approved?

Clascoterone was first approved by the FDA in 2020.

What drug class does Clascoterone belong to?

Clascoterone is in the Androgen Receptor Inhibitor class.

What is the chemical formula of Clascoterone?

Clascoterone has the molecular formula C24H34O5 and a molecular weight of 402.53 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval2020-08-26
AgencyFDA
Targets1
Indications1
FormulaC24H34O5
DrugCentral ID5410
Interactive profile